Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Nw<P
bklz
SBf FZw)
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 8k!6b\Imz
k3hkk:W
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© v.g"{us
X;GfPw.m
1.Co-stimulators (or co-stimulating molecules) _6LoVS
*e4TSqC|
2.NK-kB $|<m9CW
(4+1lOd
3.Immunoglobulin superfamily C7qYiSv
ygViPz
<J
4.antigen-presenting cell (APC) AXW!]=?X
D3]BTkMMS;
5.death domain ')TPF{\#
*HlDS22
6.CCR and CXCR hnxc`VX>g
!]b@RUU
7.Lectin (or mitogen) #gv4
nX5C<Ky
8.Clusters of differentiation, CD) Ijo(^v@
Z9
w:&oa@
9.B7 family 8vD3=yK%^
b|?;h21rG
10.Cytotoxic T lymphocyte, CTL) s>[{}7ca
y-+G
wa3
11.IL-15 and IL-15 receptor (IL-15R) nX[;^v/
}~I|t!GL
12.MHC restriction '}{?AUDx
>BoSw&T$Q
13.Affinity-chromatography +{-]P\oc
VifmZ;S@Y
14.Cyctosprin A, CsA tOg=zXm
q=0 pQ
1>
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) m|4LbWz
z`#_F}v,m/
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© =vEkMJOs
h~UJCnzS
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ,wK 1=7
-9&g[
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 'JZ_
A,<@m2
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ O),I[kb
W_JhNe
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 1N.tQ^
C*pLq5s
ÃâÒßѧרҵ£º kI+b <$:D
3B#!2|
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ NG)7G
-\,VGudM}
Ïû»¯ÄÚ¿Æ£º 3"tg+DncC
SALCuo"L
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ jt%
WPkY:
cYD1~JX.
ѪҺ²¡Ñ§×¨Òµ£º Ar5JP_M`E
C->[$HcRa
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿